Compare Stocks → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:DCTHNYSE:ISRNASDAQ:NVNONYSE:RVP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$4.70+4.9%$4.47$2.25▼$7.99$119.44M0.53220,782 shs335,142 shsISRIsoray$0.37$0.19▼$0.45$54.57M1.48290,697 shs145,000 shsNVNOenVVeno Medical$4.78-0.4%$5.53$2.51▼$6.97$63.67M1.17119,252 shs35,906 shsRVPRetractable Technologies$1.05+1.0%$1.20$0.95▼$1.88$31.44M2.1179,472 shs116,178 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems+4.92%-6.10%+9.70%+18.56%-16.90%ISRIsoray0.00%0.00%0.00%0.00%0.00%NVNOenVVeno Medical-0.42%-5.72%-16.14%+19.50%+4.60%RVPRetractable Technologies+1.94%-5.41%-12.50%-14.63%-43.24%Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCTHDelcath Systems2.6062 of 5 stars3.52.00.00.01.15.00.6ISRIsorayN/AN/AN/AN/AN/AN/AN/AN/ANVNOenVVeno Medical0.1871 of 5 stars0.02.00.00.01.81.70.6RVPRetractable TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCTHDelcath Systems3.00Buy$18.50294.04% UpsideISRIsorayN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/ACurrent Analyst RatingsLatest NVNO, DCTH, RVP, and ISR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2024DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCTHDelcath Systems$2.07M57.70N/AN/A$0.72 per share6.52ISRIsoray$10.80M0.00N/AN/A$0.43 per share0.00NVNOenVVeno MedicalN/AN/AN/AN/A$3.47 per shareN/ARVPRetractable Technologies$43.60M0.72$0.02 per share62.19$3.31 per share0.32Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCTHDelcath Systems-$47.68M-$2.97N/AN/AN/A-2,308.86%-563.60%-111.13%5/27/2024 (Estimated)ISRIsoray-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/ANVNOenVVeno Medical-$23.52M-$1.92N/AN/AN/AN/A-70.17%-64.68%5/6/2024 (Estimated)RVPRetractable Technologies-$7.01M-$0.24N/A∞N/A-16.08%-6.86%-3.78%N/ALatest NVNO, DCTH, RVP, and ISR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/26/2024Q4 23DCTHDelcath Systems-$0.67-$0.48+$0.19-$0.48$0.48 million$0.54 million 2/29/2024Q4 2023NVNOenVVeno MedicalN/A-$0.32-$0.32-$0.32N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCTHDelcath SystemsN/AN/AN/AN/AN/AISRIsorayN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCTHDelcath SystemsN/A2.262.06ISRIsorayN/A14.3813.99NVNOenVVeno MedicalN/A34.2234.23RVPRetractable Technologies0.018.286.41OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCTHDelcath Systems61.12%ISRIsoray11.32%NVNOenVVeno Medical34.71%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipDCTHDelcath Systems21.10%ISRIsoray2.42%NVNOenVVeno Medical17.00%RVPRetractable Technologies55.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDCTHDelcath Systems7625.44 million20.07 millionOptionableISRIsorayN/A142.11 million138.67 millionNot OptionableNVNOenVVeno Medical1913.32 million11.05 millionOptionableRVPRetractable Technologies19029.94 million13.47 millionOptionableNVNO, DCTH, RVP, and ISR HeadlinesSourceHeadlineRetractable Technologies And 2 Other Penny Stocks Insiders Are Buyingbenzinga.com - April 17 at 10:34 AMRetractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 17 at 2:14 AMHead to Head Survey: Pro-Dex (NASDAQ:PDEX) and Retractable Technologies (NYSE:RVP)americanbankingnews.com - April 17 at 1:28 AMRetractable Technologies CEO acquires $46.4k in stockuk.investing.com - April 10 at 2:23 AMRetractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - April 9 at 2:20 AMRVP Stock Earnings: Retractable Technologies Reported Results for Q4 2023investorplace.com - April 8 at 2:02 PMRetractable Technologies, Inc. Reports Results for 2023businesswire.com - March 29 at 3:20 PMRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholdersbusinesswire.com - March 29 at 3:15 PMJourney Medical And 2 Other Stocks Under $4 Insiders Are Buyingmsn.com - March 28 at 11:51 AMRetractable Technologies And 3 Other Stocks Under $4 Insiders Are Buyingmsn.com - March 27 at 10:32 AMTraeger And 3 Other Stocks Under $5 Insiders Are Buyingmsn.com - March 18 at 10:09 AMRetractable Technologies CEO acquires $6k in company stockuk.investing.com - March 17 at 2:19 AMRetractable Technologies, Inc.edition.cnn.com - March 14 at 6:56 PMBrightcove And 2 Other Stocks Under $3 Insiders Are Buyingmsn.com - March 13 at 12:53 PM$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buyingbenzinga.com - March 11 at 3:41 PMRetractable Technologies Inc.barrons.com - February 24 at 12:29 PMRezolute And 3 Other Penny Stocks Insiders Are Buyingbenzinga.com - February 21 at 10:34 AMTilray Brands And 2 Other Stocks Under $2 Insiders Are Buyingmarkets.businessinsider.com - January 16 at 10:15 AMMonitoring Retractable Technologies Inc (RVP) after recent insider movementsknoxdaily.com - January 1 at 9:18 AMRetractable Technologies says syringes not impacted by FDA advisorymsn.com - December 1 at 6:48 PMRetractable Technologies, Inc. Not Impacted by FDA Safety Communicationfinance.yahoo.com - December 1 at 5:55 PMInsiders Buying Retractable Technologies And 3 Other Penny Stocksmsn.com - November 29 at 8:48 AMRetractable Technologies, Inc. Results for the Periods Ended September 30, 2023finance.yahoo.com - November 14 at 5:15 PMRetractable Technologies Inc RVPmorningstar.com - November 12 at 2:49 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDelcath SystemsNASDAQ:DCTHDelcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.IsorayNYSE:ISRIsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.enVVeno MedicalNASDAQ:NVNOenVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. Retractable TechnologiesNYSE:RVPRetractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. The company was incorporated in 1994 and is headquartered in Little Elm, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.